Results 141 to 150 of about 51,637 (256)
Ocular myasthenia gravis management. [PDF]
Kupersmith MJ, Wolfe GI, Kaminski H.
europepmc +1 more source
This study demonstrated significant treatment efficacy and safety of incobotulinumtoxinA injection in Japanese patients with chronic sialorrhea caused by Parkinson's disease and other neurological conditions. Suppression of salivary secretion and improvement in drooling symptoms were also observed throughout 48 weeks.
Nobutaka Hattori +15 more
wiley +1 more source
As amyotrophic lateral sclerosis (ALS) clinical trials rapidly expand, efficient site operations are critical to success. A discussion among U.S. research sites identified ten practical strategies, creating a framework to strengthen infrastructure, streamline operations, and ensure sustainability of ALS clinical research sites while supporting ...
Erica Scirocco +13 more
wiley +1 more source
Exploring the impact of age of onset on stereoacuity in patients with myasthenia gravis. [PDF]
Cheng CY, Chiu HC, Hung CF, Yeh JH.
europepmc +1 more source
Myasthenia gravis and prostatic neoplasia: a rare association
Mafalda Sá Pereira +3 more
openalex +2 more sources
ABSTRACT Introduction/Aims Congenital myasthenic syndromes (CMS) are often underdiagnosed due to phenotypic overlap with other neuromuscular disorders. Limited epidemiological data and low awareness hinder early diagnosis, which is key for effective treatment.
Elena Rossini +10 more
wiley +1 more source
Mitochondrial proteins contribute to the pathogenesis of myasthenia gravis. [PDF]
Cao F +7 more
europepmc +1 more source
Juvenile Ocular Myasthenia Gravis in a 3-Year-Old African Girl: A Case Report
Elisamia Ngowi +8 more
openalex +1 more source

